Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
REVENUE	$ 1,001,252	$ 381,899	$ 2,197,734	$ 1,054,805
Cost of revenue	508,877	100,782	1,120,435	327,084
NET REVENUE	492,375	281,117	1,077,299	727,721
EXPENSES
General and administrative expenses [Notes 7, 8 and 9]	3,688,868	2,179,928	9,675,299	6,292,225
Research and development expenses	681,411	447,639	1,507,634	879,661
TOTAL OPERATING EXPENSES	4,370,279	2,627,567	11,182,932	7,171,886
Other income [Note 3]	(8,637)		(25,604)
Accretion and amortization expense [Note 5]	380,692	26,058	722,795	26,058
Change in fair value of derivative liabilities [Note 6]	(349,714)	(1,503)	(783,193)	(1,503)
NET LOSS BEFORE INCOME TAXES	(3,900,245)	(2,371,005)	(10,019,631)	(6,468,720)
Income taxes
NET LOSS	(3,900,246)	(2,371,005)	(10,019,631)	(6,468,720)
Less: Preferred Stock Dividends [Note 8]	218,904	23,671	649,336	23,671
NET LOSS ATTRIBUTED TO COMMON STOCKHOLDERS	(4,119,149)	(2,394,676)	(10,668,968)	(6,492,391)
Translation adjustment	366,788	(234,820)	187,247	(273,735)
COMPREHENSIVE LOSS	$ (3,752,361)	$ (2,629,496)	$ (10,481,721)	$ (6,766,126)
LOSS PER SHARE, BASIC AND DILUTED	$ (0.111)	$ (0.066)	$ (0.288)	$ (0.181)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	37,256,315	36,176,520	37,038,957	35,826,398